Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Determining the mean/median time between botulinum toxin-A injection within the treatment of patients with spasticity after stroke in relation to the botulinum toxin dose from a healthcare insurance database in the Netherlands.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Mean time to next injection per brand | From baseline up to end of data collection (January 2012 up to December 2016) | |
| Median time to next injection per brand | From baseline up to end of data collection (January 2012 up to December 2016) | |
| Dosing of botulinum toxin-A in daily practice in relation to time to next injection | From baseline up to end of data collection (January 2012 up to December 2016) |
| Measure | Description | Time Frame |
|---|---|---|
| Average cost per year per brand per patient | From baseline up to end of data collection (January 2012 up to December 2016) | |
| Exploring factors like age, gender, time since diagnosis stroke that influence dosing and time between botulinum toxin-A treatments |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
All patients selected from the database claimed within the code 313 will be included in the descriptive analyses.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Ipsen Medical Director | Ipsen | Study Director |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Ipsen Facility | Hoofddorp | 2132LS | Netherlands |
Not provided
Not provided
Not provided
Not provided
| From baseline up to end of data collection (January 2012 up to December 2016) |
| Time interval between 2 injections of the same brand | From baseline up to end of data collection (January 2012 up to December 2016) |